Clinical Trials Logo

Filter by:
NCT ID: NCT04643756 Completed - Clinical trials for Chronic Low-back Pain

Investigation of the Effects of Two Different Treatment Programs on Chronic Low Back Pain

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This study was planned to examine the effects of two different treatment programs on pain intensity, back awareness, functional and psychosocial factors in patients with chronic low back pain.

NCT ID: NCT04643730 Completed - Interventions Pain Clinical Trials

The Effects on Pain of Acupressure and Foot Reflexology Before Heel Lancing in Newborns

Start date: October 30, 2017
Phase: N/A
Study type: Interventional

This study aimed to determine the effects of foot reflexology and acupressure on the KI3 and St36 points on pain during interventions when these procedures were administered before heel lancing in term newborns.

NCT ID: NCT04643522 Completed - Covid19 Clinical Trials

Semen Parameters and COVID-19 in Infertile Men

Start date: January 7, 2020
Phase:
Study type: Observational

Coronavirus Disease-19 (COVID-19) is a global pandemics which affects many organs and systems with a range of morbidities and high mortality rates. There are a number of studies revealed that COVID-19 may affect the testes and male genital tract which may in turn disrupt the gonadal functions.The current study aimed to evaluate the effect of COVID-19 on semen parameters and sex-related hormone levels.

NCT ID: NCT04643392 Completed - Lipedema Clinical Trials

Physiotherapy Applications in Upper Extremity Lipedema

Start date: September 2, 2019
Phase:
Study type: Observational [Patient Registry]

Lipedema which causes excessive accumulation of fat in the subcutaneous tissue, is a rare, progressive disease. This disease generally affects women, following puberty or early adulthood and usually results in the slow increase of the circumference of the legs and/or arms, bilaterally. In a typical presentation of lipedema, the enlargement of the lower extremities is disproportionately greater than that of the trunk and upper extremities When first described in 1940, lipedema was thought to exclusively affect the lower extremities. However, as the disease has been recognized over the years, lipedema has been reported to affect the upper extremities. Upper extremity lipedema, with no involvement of the lower extremities is an extremely rare incident.

NCT ID: NCT04643236 Completed - Gingivitis Clinical Trials

Increased Knowledge Improve Oral Hygiene In Patients With Gingivitis

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Proper plaque control is essential for to maintain oral and general health therefore, improving patient motivation is crucial for to prevent oral diseases including periodontal diseases. The aim of this clinical trial is to evaluate the effect of periodontal health education session (PHES) including the pathogenesis and consequences of periodontal diseases on oral hygiene motivation in patients with gingivitis.

NCT ID: NCT04642716 Completed - Periodontitis Clinical Trials

Evaluation of Free Aminoacids in Saliva as A Diagnostic Biomarker of Periodontal Disease

Start date: April 20, 2015
Phase: N/A
Study type: Interventional

Amino acids (AAs) are organic molecules that are associated with inflammation and innate immunity diseases with critical roles in the cell repair and protection process. Our aim was to identify the free amino acids in saliva of a group of periodontitis patients and healthy individuals and additionally to assess their levels in different periodontal disease types and compare it to the healthy individuals.

NCT ID: NCT04642625 Completed - Pain, Postoperative Clinical Trials

Comparison of Ultrasound-guided Bilateral ESP Block and Wound Infiltration for Spinal Surgical Analgesia

Start date: April 1, 2021
Phase:
Study type: Observational

The aim of our study is to determine the superior procedure in analgesia management by comparing the traditional wound infiltration technique with the ultrasound-guided bilateral erector spina plan block technique in spinal surgery patients.

NCT ID: NCT04642469 Completed - Clinical trials for Carcinoma, Non- Small Cell Lung

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

MERMAID-2
Start date: November 30, 2020
Phase: Phase 3
Study type: Interventional

This is a Phase III double-blind, placebo-controlled study of Durvalumab versus Placebo in patients with stage II-III NSCLC who are MRD-positive following curative intent therapy.

NCT ID: NCT04642326 Active, not recruiting - Covid19 Clinical Trials

Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis

Start date: June 26, 2020
Phase: N/A
Study type: Interventional

Clinical research study that evaluates the effect of Turkish Beam-Selective UV developed by RD GLOBAL ARAŞTIRMA GELİŞTİRME SAĞLIK İLAÇ İNŞAAT YATIRIMLARI A.Ş. use into Intravascular, Intrapulmonary, Intratracial, Intrarespiratory area. Bacteria, Fungal and Virus-based pathogens systematically to collect and evaluate specific clinical performance and safety data. This Clinical Research aims to investigate the effectiveness of the treatment group and control group mortality rates, intensive care hospitalization times, monitoring the virus load by PCR, and the treatment effectiveness of UVC application. This Clinical Research covers determining the treatment effectiveness and reliability of UVC application to patient groups, the details of which are determined in the protocol.

NCT ID: NCT04642040 Recruiting - Covid19 Clinical Trials

Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia

Start date: June 30, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the efficacy of pulmonary rehabilitation (PR) program to patients with Sars-CoV-2 pneumonia in the post-acute period on pulmonary functions, exercise capacity and anxiety level. 100 patients diagnosed with Sars-CoV-2 pneumonia will be enrolled in this prospective, interventional study according to inclusion/exclusion criteria. Patients will be evaluated and a personalized PR program will be organized before hospital discharge. After discharge, the pulmonary rehabilitation program will continue in telerehabilitation. In the telerehabilitation program, exercises will be supervised by a physiotherapist two days a week, and patients will be asked to do the exercises themselves for the other 3 days. Patients will also receive exercise videos for these 3 days. Patients will be followed for 4 weeks and will be called for final evaluation